Saenz, E.V. , Golibkhon, A. and Ibragim, Y. 2023. A comprehensive analysis of visfatin drug in type 2 diabetes, insulin resistance, and cardiovascular disease. Journal of Prevention, Diagnosis and Management of Human Diseases . 3, 02 (Jul. 2023), 1–8. DOI:https://doi.org/10.55529/jpdmhd.32.1.8.